Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

2(33.3%)

Phase 2

1(16.7%)

N/A

1(16.7%)

Phase 3

1(16.7%)

Early Phase 1

1(16.7%)

6Total

Phase 4(2)

Phase 2(1)

N/A(1)

Phase 3(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05959343Not ApplicableCompleted

Enhanced Recovery After Surgery in Oblique Lumbar Interbody Fusion

Role: collaborator

NCT00931970Unknown

Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)

Role: collaborator

NCT01856140Early Phase 1Completed

Treatment of Tendon Injury Using Mesenchymal Stem Cells

Role: collaborator

NCT00981305Phase 3Completed

Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors

Role: collaborator

NCT00950664Phase 4Completed

A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia

Role: collaborator

NCT02431039Phase 2Completed

Comparison Between NEOSORB Plus and NEOSORB

Role: collaborator

NCT01736033Phase 4Unknown

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients

Role: collaborator

NCT02042963Unknown

KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)

Role: collaborator

All 8 trials loaded